Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450.
D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000378:metabolism*; D003497:Cyclic N-Oxides / Q000378:metabolism*; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism*; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D008862:Microsomes, Liver / Q000201:enzymology*; D009243:NAD / Q000378:metabolism*; D009249:NADP / Q000378:metabolism*; D010084:Oxidation-Reduction; D011763:Pyrrolizidine Alkaloids / Q000378:metabolism*; D051381:Rats
D000972:Antineoplastic Agents, Phytogenic; D003497:Cyclic N-Oxides; D011763:Pyrrolizidine Alkaloids; D009243:NAD; C013095:indicine-N-oxide; D009249:NADP; D003577:Cytochrome P-450 Enzyme System